HEALTHCARE REALTY TRUST INC
HRNYSETrading Snapshot
- Day Range
- $17.86 – $18.08
- 52-Week Range
- $16.31 – $22.04
- Volume
- $4.86B
- Avg Volume
- $4.15B
- Shares Outstanding
- 350.8M
- Next Earnings
- Nov 13, 2026
Fundamentals Snapshot
- Annual Revenue
- $1.18B
- Last Q Revenue
- $282M
- P/E Ratio
- -68.5
- P/S Ratio
- 5.5x
- EPS (TTM)
- $-0.25
- Dividend Yield
- 5.34%
- Dilution (1yr)
- −0.4%
Why Investors Own HR
- ✓High-growth profile — revenue up +43.0% YoY with expanding US Equity exposure.
- ✓Healthy economics — 49% gross margin and 15% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
HEALTHCARE REALTY TRUST INC
HR
StockOtter · stockotter.spaceAbout HEALTHCARE REALTY TRUST INC
Healthcare Realty Trust operates as a Real Estate Investment Trust (REIT), specializing in the acquisition, development, financing, and active management of income-generating real estate assets, predominantly serving outpatient healthcare providers throughout the United States. By September 30, 2020, its extensive portfolio comprised 211 properties located across 24 states, collectively spanning 15.5 million square feet and valued at approximately $5.5 billion. The company further provided comprehensive leasing and property management solutions for 11.9 million square feet nationwide.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Ratings
ⓘLatest News & Updates
Corient Private Wealth LP Purchases 30,584 Shares of Healthcare Realty Trust Incorporated $HR
Corient Private Wealth LP bought a new stake in Healthcare Realty Trust Incorporated (NYSE: HR) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional
State Street Corp Reduces Stock Position in Healthcare Realty Trust Incorporated $HR
State Street Corp trimmed its stake in shares of Healthcare Realty Trust Incorporated (NYSE: HR) by 1.9% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Comm
Down 5.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Healthcare Realty Trust (HR)
The heavy selling pressure might have exhausted for Healthcare Realty Trust (HR) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revis
PureTech Announces Successful End-of-Phase 1 Meeting with U.S. Food and Drug Administration (FDA) and Receipt of Fast Track Designation for LYT-200 in Relapsed/Refractory (R/R) High-Risk Myelodysplast
[url="]PureTech Health plc[/url] (LSE: PRTC) ("PureTech" or the "Company"), a hub-and-spoke biotherapeutics company dedicated to giving life to science and tran
ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated a median progression-free survival of 14.3 months as 1st-line therapy in patients with HER2-mutant advanced non-small cell lung cancer in DESTIN
Positive results from the DESTINY-Lung04 Phase III trial showed AstraZeneca and Daiichi Sankyo's ENHERTUÂ (fam-trastuzumab deruxtecan-nxki) demonstrated a stat
Ivonescimab Monotherapy Demonstrates a Statistically Significant & Clinically Meaningful Benefit Compared to Pembrolizumab Monotherapy in PD-L1-Positive Advanced NSCLC in Akeso's HARMONi-2 Study Condu
Summit Therapeutics Inc. (NASDAQ: SMMT) today noted that its partner Akeso Inc. [url="]announced[/url] that updated data, including overall survival (OS), from